Skip to main content
. 2022 Jul 29;28(10):706.e1–706.e10. doi: 10.1016/j.jtct.2022.07.024

Table 3.

Adverse Effects of Vaccines

First Dose (N = 122) Second Dose (N = 105) Third dose (N = 74)
Tenderness 85 (70.0%) 81 (77.0%) 46 (62.0%)
≥Grade 2 4 4 2
≥Grade 3 0 0 0
Erythema 0 0 0
≥Grade 2 0 0 0
≥Grade 3 0 0 0
Swelling 0 0 0
≥Grade 2 0 0 0
≥Grade 3 0 0 0
Fever 1 (0.8%) 3 (2.9%) 2 (2.7%)
≥Grade2 0 0 1
≥Grade3 0 0 0
Chills 1 (0.8%) 2 (1.9%) 2 (2.7%)
≥Grade 2 0 0 0
≥Grade 3 0 0 0
Myalgia 5 (4.1%) 3 (2.9%) 3 (4.1%)
≥Grade 2 3 2 2
≥Grade 3 2 2 0
Fatigue 17 (14.0%) 21 (20.0%) 12 (14.0%)
≥Grade 2 7 9 5
≥Grade 3 5 3 2
Arthralgia 2 (1.6%) 3 (2.9%) 3 (4.1%)
≥Grade 2 2 2 3
≥Grade 3 1 2 0
Headache 2 (1.6%) 3 (2.9%) 2 (2.7%)
≥Grade 2 1 1 1
≥Grade 3 0 1 0
Gastrointestinal symptoms 2 (1.6%) 5 (4.8%) 1 (1.4%)
≥Grade 2 1 4 1
≥Grade 3 0 1 0
Others 2 (1.6%) 5 (4.8%) 1 (1.4%)
≥Grade 2 0 3 0
≥Grade 3 0 2 0

Gastrointestinal symptoms include nausea, vomiting and diarrhea. Others include shortness of breath, rash, dizziness, night sweats, and Guillain-Barré syndrome. Data are unavailable for 2 patients, due to death.